US64132K2015 - Common Stock
NEUBASE THERAPEUTICS INC
NASDAQ:NBSE (5/3/2024, 7:08:15 PM)
After market: 0.3891 -0.02 (-3.93%)0.405
-0.01 (-1.72%)
NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The company is headquartered in Pittsburgh, Pennsylvania. The company went IPO on 2014-05-28. The company is developing a modular peptide-nucleic acid (PNA) antisense oligo (PATrOL) platform to address genetic diseases, with a single, cohesive approach. The Company’s programs are NT-0100 in HD, NT-0200 in myotonic dystrophy type 1 (DM1) and NT-0300 in KRAS-driven cancers. The NT-0100 program is a PATrOL-enabled therapeutic program being developed to target the mutant expansion in the HD DNA or RNA. The NT-0200 program is a PATrOL-enabled therapeutic program being developed to target the mutant expansion in the DM1 disease RNA. The NT-0300 program is a PATrOL-enabled therapeutic program being developed to target the mutated KRAS gene. The company uses its platform to address diseases which have a genetic source, with an initial focus on gene silencing in DM1, Huntington’s disease (HD), and oncology and in gene editing applications. The company also focused on identifying and evaluating multiple indications for potential development.
NEUBASE THERAPEUTICS INC
350 Technology Drive
Pittsburgh PENNSYLVANIA 15219
P: 14127633350
CEO: Dietrich Stephan
Employees: 37
Website: https://www.neubasetherapeutics.com/
Curious about the stocks that are showing activity after the closing bell on Friday?
PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”) today reported that it received a...
AppTech Payments stock is down on Tuesday after the company priced shares of APCX in a public offering of 2 million units.
NeuBase Therapeutics stock is down on Tuesday as NBSE investors react to details concerning an upcoming special shareholder meeting.
It's time to dive into the biggest pre-market stock movers on Tuesday as we check out all of the hottest news moving shares this morning!
Here you can normally see the latest stock twits on NBSE, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: